Biotech | May 16, 2024
Roche says weight loss drug shows promising results in early trial
Roche announced promising results from an early-stage trial of its experimental weight loss drug, CT-388, marking a significant stride in its endeavor to penetrate the burgeoning obesity treatment market. Acquired through its nearly $3 billion takeover of Carmot Therapeutics in December, the drug is poised to challenge established players like Novo Nordisk and Eli Lilly… Continue reading Roche says weight loss drug shows promising results in early trial